Financial Statement

Fiscal Year Ends	:	December
( in million Rupiah except Par Value, Per Share Data and Ratios )
Statement Date	:	2024-03-31
Balance Sheet
Cash & Cash Equivalents	:	149,606
Curr. Assets	:	16,371,531
Fixed Assets	:	1,918,538
Total Assets	:	18,290,069
Curr. Liabilities	:	14,686,763
Long Term Debt	:	0
Minority Interest	:	0
Total Liabilities	:	14,686,763
Paid-Up Capital	:	44,459
Total Equity	:	3,603,306
Income Statement
Total Sales	:	335,776
Gross Profit	:	133,691
Operating Profit	:	19,076
Net Income	:	14,849
Cash Flow Statement
Cash From Operating Act	:	-317,128
Cash From Investing Act	:	63,689
Cash From Financing Act	:	1,727
Per Share Data (in IDR)
EPS	:	0.33
Book Value	:	81.05
Financial Ratios
Der	:	4.08
Roa	:	0.18
Roe	:	0.02
Npm	:	0.04
Opm	:	0.06
Growth Year to Year
Sales (%)	:	100.00%
Net Income (%)	:	100.00%
Total Assets (%) (%)	:	100.00%
Total Liabilities (%)	:	100.00%

1	Perajin tempe di Ponorogo siasati ukuran imbas kenaikan harga kedelai

2	OPAQUE Akuisisi Teknologi AI Kriptografi Abu Dhabi Dari TII

3	TIME Nobatkan Xenco Medical sebagai Salah Satu dari TIME100 Most Influential Companies in the World

4	Canton Fair Ke-139: Pertumbuhan "Sleep Economy" Dorong Inovasi "Home Textile"

5	Brookfield dan The Nuclear Company Bermitra Untuk Mendirikan Perusahaan Baru Guna Mempercepat Pengembangan Nuklir di A.S

Perajin tempe di Ponorogo siasati ukuran imbas kenaikan harga kedelai